Suzhou, China 11/13/17—Gene synthesis and synthetic biology company Synbio Technologies has listed its stock on China’s NEEQ (National Equities Exchange and Quotations) over-the-counter exchange. The company stated that the listing will supply it with the resources to grow, and that is the first DNA manufacturing firm listed on the NEEQ.

Synbio provides services for gene synthesis, plasmid preparation, PCR cloning, subcloning, site-directed mutagenesis and vector construction. It calls its Syno Synthesis Platform a Genotype-Phenotype-Synotype (GPS) platform for DNA manipulation and synthesis. According to China Daily, 2,240 companies have newly listed on the NEEQ so far this year. The market is designed to provide financing for small- and medium-sized firms.